These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2009-017222-39 Ensayo clínico aleatorizado, doble ciego, doble enmascarado, multicéntrico para evaluar la eficacia y seguridad de 5 mg de mifepristona oral comparado con triptorelina IM administrados durante 4 meses... not-yet-due
Not reported Terminated 2016-001011-21 A prospesctive, open-label 12-weeks treatment study to determine the effect of tadalafil 5 mg on clitoral blood flow in menopausal and hipertensive women with sexual interest and arousal disorder 2019-02-26 due-trials
Ongoing 2018-002367-26 A randomized, double-blind, three-arm, parallel-group, multicentre superiority study assessing the efficacy and safety of mifepristone (2.5 mg and 5 mg) vs. placebo for the treatment of endometriosis ... not-yet-due